Stephen G. Patterson

691 total citations
16 papers, 546 citations indexed

About

Stephen G. Patterson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Stephen G. Patterson has authored 16 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Stephen G. Patterson's work include Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Stephen G. Patterson is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Stephen G. Patterson collaborates with scholars based in United States, United Kingdom and Spain. Stephen G. Patterson's co-authors include Julio M. Pow‐Sang, Michael J. Diaz, Walter M. Stadler, Charles E. Riggs, Johann S. de Bono, William McCulloch, Vasilios Karavasilis, Lan Chen, David P. Dearnaley and Celestia S. Higano and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and The Journal of Urology.

In The Last Decade

Stephen G. Patterson

16 papers receiving 526 citations

Peers

Stephen G. Patterson

PRM

ONCOL

EDM

Y. Ning United States

Andrea Freschi Italy

Karen Novik United Kingdom

Michael S. Stahler United States

Mark S. Chapman United States

Aymen Shatnawi United States

Sui-Fan Tong China

Akiko Tanabe Japan

April M. Lew Canada

Kenneth W. Batchelor United States

Y. Ning United States

Stephen G. Patterson

292 ×1.0

71 ×0.4

PRM

105 ×0.7

ONCOL

57 ×0.8

53 ×0.8

EDM

Citations per year, relative to Stephen G. Patterson Stephen G. Patterson (= 1×) peers Y. Ning

Countries citing papers authored by Stephen G. Patterson

Since Specialization

Citations

This map shows the geographic impact of Stephen G. Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen G. Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen G. Patterson more than expected).

Fields of papers citing papers by Stephen G. Patterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen G. Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen G. Patterson. The network helps show where Stephen G. Patterson may publish in the future.

Co-authorship network of co-authors of Stephen G. Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen G. Patterson. A scholar is included among the top collaborators of Stephen G. Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen G. Patterson. Stephen G. Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Basu, Malini, et al.. (2011). Time interval as a quality measure: What is our baseline prior to nurse navigator implementation?. Journal of Clinical Oncology. 29(27_suppl). 208–208. 1 indexed citations

Souza, Paul L. de, Begoña Mellado, C. Pfister, et al.. (2010). Randomized phase II trial of patupilone plus prednisone versus docetaxel plus prednisone in patients with chemotherapy-naïve, metastatic, castrate-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 28(15_suppl). 4553–4553. 6 indexed citations

Molife, L. Rhoda, Gerhardt Attard, Peter C.C. Fong, et al.. (2009). Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC). Annals of Oncology. 21(1). 109–113. 147 indexed citations

Jim, Heather, Brent J. Small, Stephen G. Patterson, Raoul Salup, & Paul B. Jacobsen. (2009). Cognitive impairment in men treated with luteinizing hormone–releasing hormone agonists for prostate cancer: a controlled comparison. Supportive Care in Cancer. 18(1). 21–27. 30 indexed citations

Salup, Raoul, et al.. (2008). Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer. Psycho-Oncology. 18(6). 598–605. 18 indexed citations

Molife, R., Vasilios Karavasilis, Alex Reid, et al.. (2007). Romidepsin (FK228), a histone deacetylase inhibitor: Final results of a phase II study in metastatic hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology. 25(18_suppl). 15507–15507. 16 indexed citations

Patterson, Stephen G., et al.. (2006). Management of Hot Flashes in Men with Prostate Cancer Being Treated with Androgen Deprivation Therapy. PubMed. 4(1). 30–37. 6 indexed citations

Patterson, Stephen G., et al.. (2006). Abbreviated Rasburicase Dosing for the Prevention and Treatment of Hyperuricemia in Adults at Risk for Tumor Lysis Syndrome. PubMed. 3(3). 178–182. 8 indexed citations

Patterson, Stephen G., Sheng Wei, X Chen, et al.. (2006). Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells. Oncogene. 25(45). 6113–6122. 102 indexed citations

10.

Park, Jong-Hak, Lan Chen, Thomas A. Sellers, et al.. (2006). Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men. Cancer Epidemiology Biomarkers & Prevention. 15(8). 1473–1478. 81 indexed citations

11.

Molife, R., Stephen G. Patterson, Charles E. Riggs, et al.. (2006). Phase II study of FK228 in patients with hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology. 24(18_suppl). 14554–14554. 7 indexed citations

12.

Chen, Lan, Philip Lazarus, John D. Seigne, et al.. (2004). ASP85TYR POLYMORPHISM IN THE UDP-GLUCURONOSYLTRANSFERASE (UGT) 2B15 GENE AND THE RISK OF PROSTATE CANCER. The Journal of Urology. 171(6 Part 1). 2484–2488. 57 indexed citations

13.

Diaz, Michael J. & Stephen G. Patterson. (2004). Management of Androgen-Independent Prostate Cancer. Cancer Control. 11(6). 364–373. 34 indexed citations

14.

Gottschall, Jonathan, et al.. (2003). Patterns of characterization in folktales across geographic regions and levels of cultural complexity. Human Nature. 14(4). 365–382. 17 indexed citations

15.

Patterson, Stephen G., Lodovico Balducci, & Julio M. Pow‐Sang. (2002). Controversies Surrounding Androgen Deprivation for Prostate Cancer. Cancer Control. 9(4). 315–325. 13 indexed citations

16.

Patterson, Stephen G., Lodovico Balducci, & R. Daniel Meyer. (2002). The Book of Job: a 2,500-year-old current guide to the practice of oncology: the nexus of medicine and spirituality.. PubMed. 17(4). 237–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact